ES2101866T3 - Producto alimentario liquido que contiene acido 3-guanidinopropionico. - Google Patents

Producto alimentario liquido que contiene acido 3-guanidinopropionico.

Info

Publication number
ES2101866T3
ES2101866T3 ES92918163T ES92918163T ES2101866T3 ES 2101866 T3 ES2101866 T3 ES 2101866T3 ES 92918163 T ES92918163 T ES 92918163T ES 92918163 T ES92918163 T ES 92918163T ES 2101866 T3 ES2101866 T3 ES 2101866T3
Authority
ES
Spain
Prior art keywords
guanidinopropionic acid
pct
food product
insulin
provides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92918163T
Other languages
English (en)
Inventor
Martin Durham Meglasson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Pharmacia and Upjohn Co
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/751,239 external-priority patent/US6008253A/en
Application filed by Pharmacia and Upjohn Co, Upjohn Co filed Critical Pharmacia and Upjohn Co
Application granted granted Critical
Publication of ES2101866T3 publication Critical patent/ES2101866T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

EN LA PRESENTE INVENCION SE PRESENTA UNA NUEVA COMPOSICION, UN PRODUCTO ALIMENTICIO Y LOS USOS PARA UN COMPUESTO CONOCIDO. EN PARTICULAR, EN LA PRESENTE INVENCION SE PRESENTA UNA NUEVA COMPOSICION FARMACEUTICA QUE CONTIENE ACIDO 3-GUANIDINOPROPIONICO Y UN METODO PARA LA UTILIZACION DEL ACIDO 3-GUANIDINOPROPIONICO PARA PREVENIR O TRATAR LA OBESIDAD DE PACIENTES DIABETICOS NO DEPENDIENTES DE LA INSULINA (NIDDM) PROVOCADA POR EL TRATAMIENTO DE FARMACOS ANTIDIABETICOS, TALES COMO UN FARMACO ACTIVADOR DE LA INSULINA O UN FARMACO ESTIMULADOR DE LA SECRECION DE INSULINA. EJEMPLOS DE FARMACOS ACTIVADORES DE LA INSULINA SON LAS PIOGLITAZONAS Y LOS HIDROCLORUROS DE PIOGLITAZONAS. EJEMPLOS DE FARMACOS ESTIMULADORES DE LA SECRECION DE INSULINA SON LOS GLIBURIDOS Y LOS GLIMEPIRIDOS. EN LA PRESENTE INVENCION TAMBIEN SE PRESENTA UN NUEVO PRODUCTO ALIMENTICIO QUE CONTIENE ACIDO 3-GUANIDINOPROPIONICO Y UN METODO PARA LA UTILIZACION DEL ACIDO 3-GUANIDINOPROPIONICO PARA AUMENTAR LA CAPACIDAD DE RESISTENCIA, AGUANTE Y EJERCICIO.
ES92918163T 1991-08-26 1992-08-19 Producto alimentario liquido que contiene acido 3-guanidinopropionico. Expired - Lifetime ES2101866T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75055991A 1991-08-26 1991-08-26
US07/751,239 US6008253A (en) 1991-08-26 1991-08-26 Use of 3-guanidinopropionic acid to increase endurance, stamina and exercise capacity in a mammal

Publications (1)

Publication Number Publication Date
ES2101866T3 true ES2101866T3 (es) 1997-07-16

Family

ID=27115296

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92918163T Expired - Lifetime ES2101866T3 (es) 1991-08-26 1992-08-19 Producto alimentario liquido que contiene acido 3-guanidinopropionico.

Country Status (10)

Country Link
US (1) US5900435A (es)
EP (1) EP0601001B1 (es)
JP (1) JPH06510286A (es)
AT (1) ATE151634T1 (es)
AU (1) AU2479492A (es)
DE (1) DE69219136T2 (es)
DK (1) DK0601001T3 (es)
ES (1) ES2101866T3 (es)
GR (1) GR3023848T3 (es)
WO (1) WO1993003724A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7316591A (en) * 1990-02-28 1991-09-18 Upjohn Company, The Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
TWI238064B (en) 1995-06-20 2005-08-21 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
AU3117497A (en) * 1996-05-21 1997-12-09 Pharmacia & Upjohn Company Aminoguanidine carboxylate lactams for the treatment of non-insulin-dependent diabetes mellitus
CA2260044A1 (en) * 1996-07-12 1998-01-22 Stephen Alistair Smith Novel treatment of leptine resistance
DE69738809D1 (de) * 1996-11-08 2008-08-14 Nippon Chemiphar Co Mittel zur verringerung der eigeweidefette
US7910548B2 (en) * 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
BR9810142A (pt) * 1997-06-18 2000-08-08 Smithkline Beecham Plc Tratamento de diabete com tiazolidinadiona e sulfonil-uréia
KR20060105005A (ko) * 1997-06-18 2006-10-09 스미스클라인비이참피이엘시이 티아졸리딘디온 및 메트포르민을 사용한 당뇨병의 치료
US20020004515A1 (en) * 1997-06-18 2002-01-10 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and metformin
US20010049380A1 (en) * 1997-06-18 2001-12-06 Smith Stephen Alistair Treatment of diabetes with thiazolidinedione and sulphonylurea
AP9901720A0 (en) * 1997-06-18 1999-12-31 Smithkline Beecham Plc Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitors.
GB9715295D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
GB9715306D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
US20020016287A1 (en) * 1997-07-18 2002-02-07 Smithkline Beecham P.L.C. Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide
GB9715298D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment
AR019727A1 (es) 1998-06-30 2002-03-13 Takeda Chemical Industries Ltd Composicion farmaceutica
US20040102486A1 (en) * 1998-11-12 2004-05-27 Smithkline Beecham Corporation Novel method of treatment
GB9824893D0 (en) * 1998-11-12 1999-01-06 Smithkline Beckman Corp Novel method of treatment
US6667064B2 (en) * 2000-08-30 2003-12-23 Pilot Therapeutics, Inc. Composition and method for treatment of hypertriglyceridemia
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7504118B2 (en) * 2003-04-11 2009-03-17 Fhg Corporation Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport
EP1868453A4 (en) * 2005-03-19 2008-05-07 Se Young Chung METHOD FOR PRODUCING AN EXTRACT FOR PREVENTING BZW. TREATMENT OF HYPOLIPIDEMIA AND GRAVITY FROM THE EXTRACT OF THE UPRIGHT PART OF ASTER SPATHULIFOLIUS, AND COMPOSITION COMPRISING THEREOF
WO2012138214A1 (en) * 2011-04-08 2012-10-11 Brewster Lizzy Maritza Beta-guanidinopropionic acid for the treatment of hypertension
SG10201702809XA (en) * 2012-10-18 2017-05-30 Nissin Foods Holdings Co Ltd Salty taste-enhancing agent and manufacturing method therefor, and salty taste-enhancing method
EP4072561A4 (en) * 2019-12-11 2023-11-29 Inspirna, Inc. CANCER TREATMENT METHODS
CN113598232A (zh) * 2021-07-05 2021-11-05 安徽科技学院 一种非发酵凝固型甜酒风味奶及其生产方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1195199A (en) * 1966-11-25 1970-06-17 Horlicks Pharmaceuticals Ltd Improvements in Compositions comprising Insulin.
GB1195200A (en) * 1967-02-07 1970-06-17 Horlicks Pharmaceuticals Ltd Pharmaceutical Compositions.
US3843798A (en) * 1973-03-12 1974-10-22 Stanley Drug Products Inc Methods and compositions for inducing resistance to bacterial infections
GB1552179A (en) * 1976-11-02 1979-09-12 Beecham Group Ltd Pharmaceutical compositions for treating hyperglycaemia
US5053420A (en) * 1989-10-13 1991-10-01 Pershadsingh Harrihar A Thiazolidine derivatives for the treatment of hypertension
IT1237519B (it) * 1989-11-27 1993-06-08 Impiego dell'acido guanidinacetico per indurre un incremento del contenuto muscolare di creatina
GB9003185D0 (en) * 1990-02-13 1990-04-11 Ici Plc Pharmaceutical compositions
AU7316591A (en) * 1990-02-28 1991-09-18 Upjohn Company, The Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders

Also Published As

Publication number Publication date
GR3023848T3 (en) 1997-09-30
EP0601001A1 (en) 1994-06-15
AU2479492A (en) 1993-03-16
EP0601001B1 (en) 1997-04-16
WO1993003724A1 (en) 1993-03-04
US5900435A (en) 1999-05-04
DE69219136T2 (de) 1997-08-28
DK0601001T3 (da) 1997-10-20
DE69219136D1 (de) 1997-05-22
ATE151634T1 (de) 1997-05-15
JPH06510286A (ja) 1994-11-17

Similar Documents

Publication Publication Date Title
ES2101866T3 (es) Producto alimentario liquido que contiene acido 3-guanidinopropionico.
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
US4619829A (en) Utilization of a single vitamin or a combination of various vitamins
KR840003414A (ko) 3-히드록시부탄산 또는 이 산으로부터 유도된 염을 함유하는 약학적 조성물과, 의약품으로 사용할 수 있는 3-히드록시부탄산으로부터 유도된 화합물
ES8105292A1 (es) Procedimiento para la obtencion de derivado de la difenilu- rea halogenosustituidos
FI883423A0 (fi) Foerfarande foer framstaellning av terapeutisk anvaendbara piperazinylderivat av puriner.
PT790824E (pt) Acidos carboxilicos 2,2-dicloroalcanos medicamentos contendo os mesmos e o seu uso para o tratamento da resistencia a insulina
ATE290863T1 (de) Verwendung von prolactinmodulatoren und diät zur herstellung eines medikamentes zur behandlung der fettleibigkeit
PT914110E (pt) Metodo de modulacao da micro-circulacao
KR970702291A (ko) 에퀼린의 산 이성질화체로부터 제조된 에퀼린 이중결합 이성질체(Anequilin double bond isomer from the acid isomerization of equilin)
Wechsler Recovery in amyotrophic lateral sclerosis: treated with tocopherols (vitamin E): preliminary report
ATE139690T1 (de) Ein ibuprofen enthaltendes akut-arzneimittel und seine verwendung
Jordan et al. Hunger and satiety in humans during parenteral hyperalimentation
AU7077096A (en) Selective beta 3 adrenergic agonists
US3928578A (en) Composition for control of white muscle disease
GB1453034A (en) Pharmaceutical composition for treating spasticity
RU94012067A (ru) Средство для лечения осложнений инсулинзависимого и инсулиннезависимого сахарного диабета
US2638433A (en) Pharmaceutical preparation for peptic ulcers
DE69221725D1 (de) Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
KR940013503A (ko) 동맥경화증의 예방 또는 치료용 약제학적 조성물
NO982988D0 (no) Middel for profylakse og behandling av diabetiske komplikasjoner
ATE143947T1 (de) N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten
Földi-Börcsök et al. Lymphedema and vitamins
DE69230790D1 (de) Arzneimittel zur Behandlung von durch Babesia verursachten Protozoeninfektionen
JPS6322016A (ja) 免疫刺激剤

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 601001

Country of ref document: ES